Healthcare & Life Sciences
Galapagos
Belgiumglpg.com/
Galapagos is a pre seed startup based in Japan. 1 investor tracked.
series-c-plus
series-c-plus
Stage
2020
Founded
2
Investors
About Galapagos
Galapagos is a company founded in 2020 headquartered in Belgium. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Galapagos is a Belgian biotechnology company that discovers and develops small-molecule medicines and conducts clinical trials targeting serious diseases across multiple therapeutic areas.
Explore Galapagos's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.